Companies: 10,795·Total market cap: $144.5T
Silence Therapeutics plc

Silence Therapeutics plc

SLNNASDAQHealthcare● Active
$6.23
+$0.06(+0.97%)
Market Cap$294267496
P/E Ratio
52W High$8.4
52W Low$4.19

Silence Therapeutics plc (SLN) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · SLN · as of Mar 5, 2026

Latest filing snapshot

300
+184+158.62%vs prior year

Silence Therapeutics plc (SLN) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
300
Change (1Y)
+184
Growth % (1Y)
+158.62%
Revenue / Employee
$1.9K
Net Income / Employee
$-295.4K
Market Cap
$294M

SLN Employee Count

2020 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-05300+184+158.62%
2025-02-27116+7+6.42%
2024-03-13109-13-10.66%
2023-03-15122+17+16.19%
2022-03-17105+31+41.89%
2021-03-3074

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Silence Therapeutics plc
SLN
Silence Therapeutics plcYOU
300
#2
Amarin Corporation plc
AMRN
Amarin Corporation plc
275
#3
Capricor Therapeutics, Inc.
CAPR
Capricor Therapeutics, Inc.
160
#4
AC Immune S.A.
ACIU
AC Immune S.A.
133
#5
Alto Neuroscience, Inc.
ANRO
Alto Neuroscience, Inc.
76
#6
Contineum Therapeutics, Inc. Class A Common Stock
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
41
#7
Aldeyra Therapeutics, Inc.
ALDX
Aldeyra Therapeutics, Inc.
9
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · SLN peer comparison

About SLN employees

SLN Employees · Headcount

Silence Therapeutics plc (SLN) employee data is sourced from the annual SEC 10-K filing. As of 2025, Silence Therapeutics plc had 300 full-time employees globally. Full-time employees only. Global consolidated headcount.

Silence Therapeutics plc employs 300 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1,863, reflecting the company's operational efficiency.

Silence Therapeutics plc's workforce increased by 184 (158.62%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Silence Therapeutics plc's revenue per employee of $1,863 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

SLN Employees · 5 questions

As of the latest SEC 10-K filing (2025), Silence Therapeutics plc had 300 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Silence Therapeutics plc employee counthow many employees does Silence Therapeutics plc haveSLN total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-05